Skip to content
Saturday, January 24, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Trump’s antisemitism envoy rebukes European rabbi, drawing praise from Elon Musk January 23, 2026
  • Rabbi among dozens arrested in faith leaders’ anti-ICE protest in Minnesota January 23, 2026
  • Her ancestors were expelled from Spain. Now she’s bringing bagels to Madrid. January 23, 2026
  • Facing backlash after accusing Israel of genocide, Scott Wiener steps down as Calif. Jewish Caucus co-chair January 23, 2026
  • State Senator Scott Wiener to Step Down as Jewish Caucus Co-Chair January 22, 2026
  • Resignations shake Canadian art gallery after it rejects Nan Goldin acquisition over antisemitism claims January 22, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.